Skin cancer decisions — 2025

The Board granted service connection for a right ankle disorder, skin cancer, and a thyroid disorder based on the evidence of record.

The Board granted service connection for tinnitus, while remanding the claims for skin cancer, hypertension, sleep apnea, and bilateral hip conditions.

The Board granted service connection for diabetes mellitus, type II and hypertension pursuant to the PACT Act but dismissed appeals for a kidney tumor/cyst and skin cancer on the nose.

The Veteran was granted a 40 percent evaluation for five or more painful and unstable scars, but other claims were denied.

The Board denied service connection for tinnitus, finding no evidence of a current disability and that the Veteran's symptoms did not meet the criteria for recurrent tinnitus.

The Board granted service connection for skin cancer disability, finding it related to the Veteran's in-service exposure to the sun while working as an aircraft mechanic.

The Board found that new and relevant evidence had not been received to support the veteran's claims for service connection for melanoma, sarcoma, basal cell carcinoma, COPD, and sinusitis.

The Board granted service connection for hypertension, Parkinsonism, residuals of skin cancer, actinic keratosis, and non-specific dermatitis based on the Veteran's exposure to herbicide agents during active military service.

The Board granted service connection for residuals, status post removal of malignant melanoma and its secondary conditions: lymphedema/ elephantiasis, pleuritis, and atrial fibrillation with congestive heart failure with mitral and tricuspid regurgitation.

The Board denied an initial compensable disability rating for skin cancer removal scars and remanded service connection claims for a respiratory disorder, heart disorder, and hypertension.

The Board granted an effective date of May 2, 2012 for the post-surgical scar, left eye, but denied earlier effective dates and higher disability ratings.

The appeal for service connection for skin cancer was dismissed because the March 20, 2025 VA Form 10182 was not a valid appeal following the Board's February 24, 2025 remand.

The Board remands the claims for service connection for diabetes mellitus type II, trigeminal neuralgia, and intraocular melanoma tumor of the right eye due to contaminated water exposure at Camp Lejeune for a new VA etiology opinion.

The Board remands the claims for service connection for neurological issues, right and left upper extremities, right and left foot nerve damage, and skin cancer to obtain medical examinations and opinions related to in-service exposure to lead paint and sun exposure.

The August 2024 appeal of the July 2024 rating decision that proposed a reduction of the disability rating for basal cell carcinoma (BCC) was dismissed because it did not actually decide any questions of law or fact that affects the provision of benefits.

The Board denied service connection for left and right elbow tendinitis due to the lack of evidence showing a current diagnosis, while remanding the claim for skin cancer for further development.

The Board denied the veteran's claim for service connection for right forearm skin cancer, finding no current diagnosis of skin cancer and that the Veteran's actinic keratosis is benign.

The Board remands the claims for service connection for basal cell carcinoma skin cancer and valvular heart disease with heart valve replacement to obtain additional medical evidence regarding the causal link between the Veteran's service, including exposure to herbicides and asbestos, and his diagnosed conditions.

The Board remands the claims for service connection for chronic lymphocytic leukemia and skin cancer to obtain a new medical opinion that considers all pertinent evidence of record.

The Board granted service connection for bilateral cataracts, melanoma, and bilateral knee arthritis based on the Veteran's exposure to ionizing radiation during his service.